期刊文献+

全流程信息化管理在药物Ⅰ期临床试验中的探索应用 被引量:24

Study on informationalized management system in phaseⅠclinical trials
原文传递
导出
摘要 药物Ⅰ期临床试验是新药研发中临床阶段的第一步,其数据的准确性、可靠性、可溯源性至关重要。本院引进Abs Studio-Ⅰ软件,结合本院临床试验的需求与经验,对软件的模块功能进行优化与实践,初步建立了本院药物Ⅰ期临床试验全流程信息管理系统,可实现实时记录试验过程、结构化完整转译方案、自动扫描核对样本、嵌合医院信息系统(HIS)、在线开单、数据有痕修改与管理、多用户远程登录监管等功能。该系统的应用能提升药物Ⅰ期临床试验的实施质量,增强受试者的依从性,提高研究者工作效率,同时加大研究机构对临床试验过程的监管力度。 As phase Ⅰ clinical trial is the first step of clinical study of new drugs, the accuracy, reliability and traceability of its data is of great significance. A software named AbsStudio- Ⅰ was introduced, amended and optimized according to the practical experience and requirements of phase Ⅰ clinical trials in our hospital. Within the improved modules of AbsStudio- Ⅰ, an informationalized management system for phase Ⅰ clinical trials has been established, to realize functions including realtime recording of whole implementing process, structurized protocol interpretation, auto-scanning verification, incorporated HIS, online prescription, traceable data revision and management and multi-account login and monitoring, etc. Generally, application of informationalized management system was helpful to improve the implement attributed to advantages of better subject compliance, higher investigators strength and so on. quality of phase Ⅰ clinical trials, efficiency, stronger supervision
作者 易玲 张华 钱丽芳 黄晨蓉 尤晓明 缪丽燕 YI Ling ZHANG Hua QIAN Li-fang HUANG Chen-rong YOU Xiao-ming MIAO Li-yan(Drug Clinical Trials Institution/Laboratory of Phase Ⅰ Clinical Trials, the First Affiliated Hospital of Soochow University, Suzhou JIANGSU 215006, China)
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2017年第3期134-140,共7页 Chinese Journal of New Drugs and Clinical Remedies
关键词 临床试验 Ⅰ期 信息系统 临床方案 条形码系统 在线开单 prescriptionclinical trial, phase Ⅰ information system clinical protocols barcode system online
  • 相关文献

参考文献12

二级参考文献59

  • 1国家食品药品监督管理局.药物临床试验质量管理规范[EB/OL].http://www.sfda.gov.cn,2003-08-06.
  • 2国家食品药品监督管理局.药物临床试验机构资格认定办法(试行)[EB/OL].http://www.sfda.gov.cn,2004-02-19.
  • 3国家食品药品监督管理局.药物临床试验伦理审查工作指导原则[EB/OL].http://www.sfda.gov.cn,2010-11-02.
  • 4Expert Working Group. ICH E6:Guideline for good clinical practice [ EB/OL]. http : //www. ich. org/products/guidelines/efficacy/article/efficacy - guidelines, html, 1996 - 06.
  • 5World Health Organization (WHO). Guidelines for good clinical practice (GCP) for trials on pharmaceutical products[ EB/OL]. http: //apps. who. int/prequal/info_ general/documents/TRS850/ WHO TRS 850 - Annex3. pdf, 1995 - 11.
  • 6郑磊.临床试验受试者的五大权利[J].中国处方药,2007,6(9):39-40. 被引量:8
  • 7Rand CS, Sevick MA. Ethics in adherence promotion and monitoring[J]. Control Clin Trials, 2000,21 (5) : 241.
  • 8国家食品药品监督管理局.药物临床试验机构资格认定办法(试行)[EB/OL].[2004-02-19].http://www.sdmgov.cn/WS01/CL00S8/9346.html.
  • 9国家食品药品监督管理总局.《药物临床试验质量管理规范》[EB/OL]. [ 2003 -08 -06]. http ://www. sda. gov. cn/WS01/CL0053/24473. html.
  • 10国家药品安全"十二五"规划.专栏五:国家药品监管信息系统二期工程[Z].

共引文献146

同被引文献165

引证文献24

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部